vs

Side-by-side financial comparison of Midland States Bancorp, Inc. (MSBI) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.

Midland States Bancorp, Inc. is the larger business by last-quarter revenue ($79.5M vs $75.5M, roughly 1.1× PUMA BIOTECHNOLOGY, INC.). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs -6.4%).

Rainier Bancorporation was the Seattle-based parent corporation of Rainier National Bank, a Washington state bank with branches throughout the state. Rainier traced its roots back to the National Bank of Commerce, which was founded by Richard Holyoke in 1889. The name Rainier National Bank was adopted in 1974. Rainier Bancorp expanded into Alaska with the purchase of Anchorage's People's Bank & Trust in 1983 and into Oregon with the purchase of Gresham's Mount Hood Security Bank in 1986, expa...

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

MSBI vs PBYI — Head-to-Head

Bigger by revenue
MSBI
MSBI
1.1× larger
MSBI
$79.5M
$75.5M
PBYI
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
-6.4%
MSBI

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
MSBI
MSBI
PBYI
PBYI
Revenue
$79.5M
$75.5M
Net Profit
$18.5M
Gross Margin
69.3%
Operating Margin
22.7%
Net Margin
23.2%
Revenue YoY
27.7%
Net Profit YoY
739.3%
EPS (diluted)
$0.74
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MSBI
MSBI
PBYI
PBYI
Q1 26
$79.5M
Q4 25
$85.6M
$75.5M
Q3 25
$81.1M
$54.5M
Q2 25
$82.2M
$52.4M
Q1 25
$76.1M
$46.0M
Q4 24
$93.9M
$59.1M
Q3 24
$92.7M
$80.5M
Q2 24
$90.9M
$47.1M
Net Profit
MSBI
MSBI
PBYI
PBYI
Q1 26
$18.5M
Q4 25
$-2.9M
Q3 25
$7.6M
$8.8M
Q2 25
$12.0M
$5.9M
Q1 25
$-141.0M
$3.0M
Q4 24
$-30.8M
Q3 24
$20.4M
$20.3M
Q2 24
$25.7M
$-4.5M
Gross Margin
MSBI
MSBI
PBYI
PBYI
Q1 26
Q4 25
69.3%
Q3 25
77.7%
Q2 25
76.5%
Q1 25
77.1%
Q4 24
76.4%
Q3 24
63.9%
Q2 24
77.4%
Operating Margin
MSBI
MSBI
PBYI
PBYI
Q1 26
Q4 25
-5.5%
22.7%
Q3 25
13.9%
17.6%
Q2 25
18.1%
12.7%
Q1 25
-181.2%
8.7%
Q4 24
-66.5%
22.6%
Q3 24
26.9%
27.4%
Q2 24
35.0%
-4.6%
Net Margin
MSBI
MSBI
PBYI
PBYI
Q1 26
23.2%
Q4 25
-4.9%
Q3 25
9.3%
16.2%
Q2 25
14.6%
11.2%
Q1 25
-185.4%
6.5%
Q4 24
-52.5%
Q3 24
22.1%
25.2%
Q2 24
28.3%
-9.6%
EPS (diluted)
MSBI
MSBI
PBYI
PBYI
Q1 26
$0.74
Q4 25
$-0.22
$0.26
Q3 25
$0.24
$0.17
Q2 25
$0.44
$0.12
Q1 25
$-6.58
$0.06
Q4 24
$-1.49
$0.40
Q3 24
$0.83
$0.41
Q2 24
$1.06
$-0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MSBI
MSBI
PBYI
PBYI
Cash + ST InvestmentsLiquidity on hand
$89.4M
$97.5M
Total DebtLower is stronger
$33.2M
$22.7M
Stockholders' EquityBook value
$569.5M
$130.3M
Total Assets
$6.5B
$216.3M
Debt / EquityLower = less leverage
0.06×
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MSBI
MSBI
PBYI
PBYI
Q1 26
$89.4M
Q4 25
$127.8M
$97.5M
Q3 25
$166.1M
$94.4M
Q2 25
$176.6M
$96.0M
Q1 25
$102.0M
$93.2M
Q4 24
$114.8M
$101.0M
Q3 24
$121.9M
$96.7M
Q2 24
$124.6M
$96.8M
Total Debt
MSBI
MSBI
PBYI
PBYI
Q1 26
$33.2M
Q4 25
$22.7M
Q3 25
$34.0M
Q2 25
$45.3M
Q1 25
$56.7M
Q4 24
$68.0M
Q3 24
$79.3M
Q2 24
$90.7M
Stockholders' Equity
MSBI
MSBI
PBYI
PBYI
Q1 26
$569.5M
Q4 25
$565.5M
$130.3M
Q3 25
$584.0M
$115.3M
Q2 25
$573.7M
$104.7M
Q1 25
$571.4M
$97.1M
Q4 24
$710.8M
$92.1M
Q3 24
$771.2M
$71.1M
Q2 24
$736.8M
$48.5M
Total Assets
MSBI
MSBI
PBYI
PBYI
Q1 26
$6.5B
Q4 25
$6.5B
$216.3M
Q3 25
$6.9B
$202.9M
Q2 25
$7.1B
$194.9M
Q1 25
$7.3B
$196.2M
Q4 24
$7.5B
$213.3M
Q3 24
$7.7B
$220.7M
Q2 24
$7.7B
$205.0M
Debt / Equity
MSBI
MSBI
PBYI
PBYI
Q1 26
0.06×
Q4 25
0.17×
Q3 25
0.30×
Q2 25
0.43×
Q1 25
0.58×
Q4 24
0.74×
Q3 24
1.12×
Q2 24
1.87×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MSBI
MSBI
PBYI
PBYI
Operating Cash FlowLast quarter
$14.4M
Free Cash FlowOCF − Capex
$14.4M
FCF MarginFCF / Revenue
19.1%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$41.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MSBI
MSBI
PBYI
PBYI
Q1 26
Q4 25
$125.7M
$14.4M
Q3 25
$80.0M
$9.7M
Q2 25
$28.1M
$14.1M
Q1 25
$24.7M
$3.6M
Q4 24
$176.5M
$15.6M
Q3 24
$46.5M
$11.0M
Q2 24
$31.4M
$1.0M
Free Cash Flow
MSBI
MSBI
PBYI
PBYI
Q1 26
Q4 25
$120.3M
$14.4M
Q3 25
$78.6M
$9.7M
Q2 25
$26.7M
$14.1M
Q1 25
$22.9M
$3.6M
Q4 24
$169.6M
$15.6M
Q3 24
$44.4M
$11.0M
Q2 24
$29.9M
$1.0M
FCF Margin
MSBI
MSBI
PBYI
PBYI
Q1 26
Q4 25
140.6%
19.1%
Q3 25
96.9%
17.7%
Q2 25
32.4%
26.8%
Q1 25
30.1%
7.7%
Q4 24
180.6%
26.4%
Q3 24
47.9%
13.7%
Q2 24
32.9%
2.1%
Capex Intensity
MSBI
MSBI
PBYI
PBYI
Q1 26
Q4 25
6.2%
0.0%
Q3 25
1.7%
0.0%
Q2 25
1.7%
0.0%
Q1 25
2.4%
0.1%
Q4 24
7.3%
0.0%
Q3 24
2.3%
0.0%
Q2 24
1.7%
0.0%
Cash Conversion
MSBI
MSBI
PBYI
PBYI
Q1 26
Q4 25
Q3 25
10.58×
1.10×
Q2 25
2.33×
2.41×
Q1 25
1.21×
Q4 24
Q3 24
2.28×
0.54×
Q2 24
1.22×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MSBI
MSBI

Net Interest Income$57.4M72%
Noninterest Income$22.1M28%

PBYI
PBYI

Segment breakdown not available.

Related Comparisons